152 related articles for article (PubMed ID: 24648956)
1. Expression levels of microRNA-375 in pancreatic cancer.
Song S; Zhou J; He S; Zhu D; Zhang Z; Zhao H; Wang Y; Li D
Biomed Rep; 2013 May; 1(3):393-398. PubMed ID: 24648956
[TBL] [Abstract][Full Text] [Related]
2. Expression levels of microRNA-375 in colorectal carcinoma.
Dai X; Chiang Y; Wang Z; Song Y; Lu C; Gao P; Xu H
Mol Med Rep; 2012 May; 5(5):1299-304. PubMed ID: 22377847
[TBL] [Abstract][Full Text] [Related]
3. microRNA-192, -194 and -215 are frequently downregulated in colorectal cancer.
Chiang Y; Song Y; Wang Z; Liu Z; Gao P; Liang J; Zhu J; Xing C; Xu H
Exp Ther Med; 2012 Mar; 3(3):560-566. PubMed ID: 22969930
[TBL] [Abstract][Full Text] [Related]
4. Expression levels of microRNA-192 and -215 in gastric carcinoma.
Chiang Y; Zhou X; Wang Z; Song Y; Liu Z; Zhao F; Zhu J; Xu H
Pathol Oncol Res; 2012 Jul; 18(3):585-91. PubMed ID: 22205577
[TBL] [Abstract][Full Text] [Related]
5. High dose glargine alters the expression profiles of microRNAs in pancreatic cancer cells.
Li WG; Yuan YZ; Qiao MM; Zhang YP
World J Gastroenterol; 2012 Jun; 18(21):2630-9. PubMed ID: 22690071
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-375 is downregulated in pancreatic cancer and inhibits cell proliferation in vitro.
Zhou J; Song S; Cen J; Zhu D; Li D; Zhang Z
Oncol Res; 2012; 20(5-6):197-203. PubMed ID: 23581226
[TBL] [Abstract][Full Text] [Related]
7. Correlation of miR-494 expression with tumor progression and patient survival in pancreatic cancer.
Ma YB; Li GX; Hu JX; Liu X; Shi BM
Genet Mol Res; 2015 Dec; 14(4):18153-9. PubMed ID: 26782462
[TBL] [Abstract][Full Text] [Related]
8. [Clinical significance of exosomal miR-1231 in pancreatic cancer].
Chen SL; Ma M; Yan L; Xiong SH; Liu Z; Li S; Liu T; Shang S; Zhang YY; Zeng H; Xie HL; Zuo CH
Zhonghua Zhong Liu Za Zhi; 2019 Jan; 41(1):46-49. PubMed ID: 30678416
[No Abstract] [Full Text] [Related]
9. Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis.
Gao W; Yu Y; Cao H; Shen H; Li X; Pan S; Shu Y
Biomed Pharmacother; 2010 Jul; 64(6):399-408. PubMed ID: 20363096
[TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of tumor suppressor and oncogenic miRNAs in gastric cancer.
Chen Z; Liu X; Hu Z; Wang Y; Liu M; Liu X; Li H; Ji R; Guo Q; Zhou Y
Oncol Lett; 2015 Jul; 10(1):329-336. PubMed ID: 26171025
[TBL] [Abstract][Full Text] [Related]
11. miR-21 Is a Promising Novel Biomarker for Lymph Node Metastasis in Patients with Gastric Cancer.
Xu Y; Sun J; Xu J; Li Q; Guo Y; Zhang Q
Gastroenterol Res Pract; 2012; 2012():640168. PubMed ID: 22792096
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-296-5p Promotes Cell Invasion and Drug Resistance by Targeting Bcl2-Related Ovarian Killer, Leading to a Poor Prognosis in Pancreatic Cancer.
Okazaki J; Tanahashi T; Sato Y; Miyoshi J; Nakagawa T; Kimura T; Miyamoto H; Fujino Y; Nakamura F; Takehara M; Ma B; Bando M; Kitamura S; Okamoto K; Muguruma N; Sogabe M; Takayama T
Digestion; 2020; 101(6):794-806. PubMed ID: 31563901
[TBL] [Abstract][Full Text] [Related]
13. [The expression of long non-coding RNA-LINC01410 in pancreatic cancer and its effect on proliferation and migration of pancreatic cancer cells].
Cai M; Xu L; Shen L; Zhang J
Zhonghua Yi Xue Za Zhi; 2019 May; 99(18):1406-1411. PubMed ID: 31137129
[No Abstract] [Full Text] [Related]
14. MicroRNA-127 is aberrantly downregulated and acted as a functional tumor suppressor in human pancreatic cancer.
Yu Y; Liu L; Ma R; Gong H; Xu P; Wang C
Tumour Biol; 2016 Oct; 37(10):14249-14257. PubMed ID: 27571739
[TBL] [Abstract][Full Text] [Related]
15. microRNA-218 suppresses the proliferation, invasion and promotes apoptosis of pancreatic cancer cells by targeting HMGB1.
Liu Z; Xu Y; Long J; Guo K; Ge C; Du R
Chin J Cancer Res; 2015 Jun; 27(3):247-57. PubMed ID: 26157321
[TBL] [Abstract][Full Text] [Related]
16. Expression profiling identifies microRNA signature in pancreatic cancer.
Lee EJ; Gusev Y; Jiang J; Nuovo GJ; Lerner MR; Frankel WL; Morgan DL; Postier RG; Brackett DJ; Schmittgen TD
Int J Cancer; 2007 Mar; 120(5):1046-54. PubMed ID: 17149698
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of miR-182 expression in colorectal cancer tissues and its prognostic value.
Liu H; Du L; Wen Z; Yang Y; Li J; Wang L; Zhang X; Liu Y; Dong Z; Li W; Zheng G; Wang C
Int J Colorectal Dis; 2013 May; 28(5):697-703. PubMed ID: 23474644
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of LINC00994 represses malignant behaviors of pancreatic cancer cells: interacting with miR-765-3p/RUNX2 axis.
Zhu X; Niu X; Ge C
Cancer Biol Ther; 2019; 20(6):799-811. PubMed ID: 30739523
[TBL] [Abstract][Full Text] [Related]
19. High microRNA-28-5p expression in colorectal adenocarcinoma predicts short-term relapse of node-negative patients and poor overall survival of patients with non-metastatic disease.
Tsiakanikas P; Kontos CK; Kerimis D; Papadopoulos IN; Scorilas A
Clin Chem Lab Med; 2018 May; 56(6):990-1000. PubMed ID: 29688883
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA Expression Levels and Histopathological Features of Colorectal Cancer.
Emami SS; Akbari A; Zare AA; Agah S; Masoodi M; Talebi A; Minaeian S; Fattahi A; Moghadamnia F
J Gastrointest Cancer; 2019 Jun; 50(2):276-284. PubMed ID: 29404790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
